Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eastman Chemical (EMN) Accounts Payables (2016 - 2026)

Eastman Chemical (EMN) has disclosed Accounts Payables for 18 consecutive years, with $2.0 billion as the latest value for Q1 2026.

  • For Q1 2026, Accounts Payables rose 0.71% year-over-year to $2.0 billion; the TTM value through Mar 2026 reached $2.0 billion, up 0.71%, while the annual FY2025 figure was $2.1 billion, 8.5% down from the prior year.
  • Accounts Payables hit $2.0 billion in Q1 2026 for Eastman Chemical, down from $2.1 billion in the prior quarter.
  • Across five years, Accounts Payables topped out at $2.3 billion in Q4 2024 and bottomed at $1.9 billion in Q3 2025.
  • Average Accounts Payables over 5 years is $2.0 billion, with a median of $2.0 billion recorded in 2025.
  • Year-over-year, Accounts Payables increased 21.34% in 2022 and then dropped 12.89% in 2025.
  • Eastman Chemical's Accounts Payables stood at $2.1 billion in 2022, then decreased by 4.24% to $2.0 billion in 2023, then increased by 10.96% to $2.3 billion in 2024, then fell by 8.5% to $2.1 billion in 2025, then fell by 3.29% to $2.0 billion in 2026.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $2.0 billion, $2.1 billion, and $1.9 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.